http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7776b564d2962b9b907e8e5fec9116b2
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Mukaida Naofumi Mukaida |
| name | Naofumi Mukaida |
| given-name | Naofumi |
| organization-name | From the *Department of Biological and Medical Research, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia 11211; ‡Department of Microbiology, Kanazawa Medical University, Ishikawa 920-0; §Department of Pharmacology, Kanazwa University, Kanazawa 920; and ‖Department of Molecular Preventive Medicine, University of Tokyo, Tokyo 113, Japan Department of Molecular Pharmacology, Cancer Research Institute, Kanazawa University , Japan Department of Pharmacology, Cancer Research Institute, Kanazawa University , Kanazawa 1Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan. Department of Pharmacology Kanazawa University Kanazawa Ishikawa 920 Japan §Department of Pharmacology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan Division of Molecular Bioregualtion, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa, Ishikawa 920-1192, Japan Department of Molecular Pharmacology, Cancer Research Institute, Kanazawa University, 920-0934 Kanazawa, Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University , Kanazawa; Department of Forensic Medicine, Wakayama Medical University , Wakayama Division of Molecular Bioregulation; Cancer Research Institute, Kanazawa University; Kanazawa Japan; Japan Science and Technology Agency; Core Research for Evolutionary Science and Technology; Tokyo Japan Division of Molecular Bioregulation 1 , 2 , and 3; Exploratory Project on Cancer Stem Cells 1 , 2 , and 3; Division of Molecular Genetics, Cancer Research Institute, Kanazawa University, Kanazawa 920-1192, Ishikawa, Japan 1 , 2 , and 3 Department of Forensic Medicine, Wakayama Medical University, Wakayama 641-0012, Japan Division of Molecular Bioregulation, Cancer Research Institute Kanazawa University, Kanazawa, Japan Department of Pharmacology; Cancer Research Institute, Kanazawa University ; Kanazawa, Ishikawa , Japan Department of Molecular Oncology, Cancer Research Institute, School of Medicine, Kanazawa University , Japan Department of Pharmacology, Cancer Research Institute, Kanazawa University , Ishikawa 920 , Japan 7Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan. Cancer Research Institute Division of Molecular Bioregulation Kanazawa University Ishikawa Japan Department of Pharmacology, Cancer Research Institute, and Kanazawa University , Kanazawa, Ishikawa , Japan *Department of Molecular Pharmacology, Cancer Research Institute, and Departments of Cancer Institute Kanazawa University Kanazawa Ishikawa 920 Japan †Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan *Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; From the Department of Pharmacology, Cancer Research Institute, Third Department of Internal Medicine, School of Medicine, Kanazawa University, Kanazawa; Department of Molecular Preventive Medicine and CREST, School of Medicine, University of Tokyo, Tokyo, Japan. Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; and the *Division of Molecular Bioregulation, Cancer Research Institute, and Division of Molecular Bioregulation, Cancer Research InstituteKanazawa University Kanazawa Ishikawa Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University , Japan Department of Molecular Oncology, Kanazawa University, Kanazawa, Japan6 Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan. Department of Pharmacology, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa 920-0934,3 and Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology, Chiyoda-ku, Tokyo 102-0075, Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan Divisions of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan Department of Orthopedics and Internal Medicine, Kitasato University School of Medicine , Japan; Department of Clinical Pathology, Tohoku University School of Medicine , Japan; Department of Pharmacology, Cancer Research Institute, Kanazawa University , Japan From the Department of Immunology, The Scripps Research Institute, La Jolla, CA; and the Department of Molecular Pharmacology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan. Department of Pharmacology, Cancer Research Institute , Japan ‡Department of Pharmacology and; §Cancer Research Institute, Kanazawa University, Kanazawa, Japan ¶ Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; and Department of Pharmacology, Cancer Research Institute, Kanazawa University , Tokyo Authors' Affiliations: Divisions of 1Medical Oncology, 2Tumor Dynamics and Regulation, and 3Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa; 4Department of Respiratory Medicine and Rheumatology, University of Tokushima Graduate School, Tokushima, Tokushima; and 5Tsukuba Research Laboratories, Eisai Co., Ltd., Ibaraki, Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Japan. Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan 4Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan §Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; Department of Molecular Oncology, Cancer Research Institute, Kanazawa University, Kanazawa 920-0934, Japan *Division of Molecular Bioregulation, Cancer Research Institute and *Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan; and Department of Molecular Oncology, Cancer Research Institute, Kanazawa University School of Medicine, Kanazawa,5 and Department of Pharmacology, Cancer Research Institute, School of Medicine, Kanazawa University , Kanazawa , Japan Kanazawa University , Ishikawa Department of Preventive Medicine and AIDS Research and Department of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Department of Pharmacology, Cancer Research Institute, Kanazawa University, 13-1 Takaramachi, Kanazawa 920-0934, and Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo, Tokyo 113-0033, Japan Department of Pharmacology, Cancer Research Institute, Kanazawa University , Japan Division of Molecular Bioregulation Cancer Research Institute Kanazawa University Kanazawa Ishikawa Japan ‡Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan Department of Pharmacology, Cancer Research Institute, Kanazawa University, Kanazawa 920, Japan Division of Molecular Bioregulation, Cancer Research Institute , Ishikawa , Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan; ‡Department of Molecular Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan Department of Pharmacology, Cancer Research Institute, Kanazawa University , Kanazawa, Ishikawa , Japan §Department of Molecular Pharmacology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan;; ††Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Tokyo, Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University , Kanazawa , Japan Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan Department of Pharmacology and Kanazawa University , Kanazawa, Ishikawa , Japan Division of Molecular Bioregulation, Cancer Microenvironment Research Program, Cancer Research Institute, Kanazawa University, Kanazawa, Japan ‡Division of Molecular Bioregulation and Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan. mukaida@staff.kanazawa-u.ac.jp. Department of Clinical Pathology Jichi Medical School Minamikawachi‐machi Tochigi 329–04 Department of Pharmacology, Cancer Research Institute, Kanazawa University Department of PharmacologyCancer Research InstituteKanazawa UniversityKanazawaJapan 1Division of Molecular Bioregulation and; 2Center for Target Drug Development, Cancer Research Institute,; 3Venture Business Laboratory, Kanazawa University, Kanazawa, Japan and 1Division of Molecular Bioregulation, Cancer Research Institute and Departments of ¶Division of Molecular Bioregulation, Department of Molecular Oncology, Cancer Research Institute, Kanazawa University, Isikawa, Japan Departments of Pharmacology, Kanazawa University , Kanazawa, Ishikawa 920 Japan From the Department of Pharmacology, Cancer Research Institute, and the Department of Hygiene, School of Medicine, Kanazawa University, Kanazawa, Japan; and the Department of Molecular Preventive Medicine, School of Medicine, University of Tokyo, Tokyo, Japan. Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-0934, Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University. Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University , Kanazawa, Japan Authors' Affiliations: 1Cancer Research Institute; 2Department of Pancreas and Hepatobiliary, Pancreatic Cancer Institute; 3Department of Pathology, Fudan University Shanghai Cancer Center; 4Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; and 5Division of Molecular Bioregulation, Cancer Microenvironment Research Program, Cancer Research Institute, Kanazawa University, Kanazawa, Japan Authors' Affiliations: 1Disease Control and Homeostasis, Graduate School of Medical Science, and 2Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Kanazawa, Japan; and 3Division of Cellular and Molecular Pathology, Niigata University Graduate School of Medicine, Niigata, Japan First Department of Internal Medicine, Yamagata University School of Medicine, Yamagata; Department of Pharmacology, Cancer Research Institute, Kanazawa University, Kanazawa; and Department of Molecular Preventive Medicine, Tokyo University Faculty of Medicine, Tokyo, Japan Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, Japan (N.M.). |
Incoming Links
Total number of triples: 337.